PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Sep-2025 Opella secures non-prescription approval of Cialis in Norway Opella
04-Sep-2025 The Menopause Network for Healthcare Professionals The Menopause Network
04-Sep-2025 FUJIFILM Biotechnologies Welcomes Samuel Hernandez as Site Head of Texas Facility Businesswire
04-Sep-2025 ArcaScience Raises $7M to Transform Drug Development with AI-Powered Benefit-Risk Intelligence ArcaScience
04-Sep-2025 Fidia Farmaceutici enters the UK market with the acquisition of Altacor Ltd Fidia Farmaceutici
04-Sep-2025 Resolution Therapeutics announces first patient dosed in Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease Resolution Therapeutics
04-Sep-2025 ViCentra Raises $85M to Scale Manufacturing and Accelerate Market Penetration of Kaleido Insulin Patch Pump ViCentra
04-Sep-2025 Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment Allegro
04-Sep-2025 Moberg Pharma to Expand Board of Directors and Withdraw Share Issue Authorization Moberg Pharma
04-Sep-2025 ArcaScience Raises $7M to Transform Drug Development with AI-Powered Benefit-Risk Intelligence ArcaScience
04-Sep-2025 Beckman Coulter Life Sciences and HSE•AG Partner to Revolutionize Nucleic Acid Quantification and Purification Through Liquid Handling Beckman Coulter Life Sciences
04-Sep-2025 Nottingham CRO Platelet Services appoints Director of Business Development Platelet Services
04-Sep-2025 Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors Businesswire
04-Sep-2025 ICON Announces CEO Transition Businesswire
04-Sep-2025 O’Reilly Scales Global Training Program with ON24 Intelligent Engagement Platform Businesswire
04-Sep-2025 Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium Businesswire
04-Sep-2025 Atlas Venture Announces $400 Million Third Opportunity Fund Businesswire
04-Sep-2025 Orbital Therapeutics Appoints Accomplished Drug Developer Adam Raff, M.D., Ph.D., as Senior Vice President, Clinical Development Businesswire
04-Sep-2025 IFF’s Designed Enzymatic Biomaterials™ Platform Sees First Large-Scale Use in Home Care Applications Businesswire
04-Sep-2025 A New Set of Palantir Customers Takes the Spotlight at AIPCon 8 Businesswire